Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8240282 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 9 Pages |
Abstract
Grid therapy provided a pronounced therapeutic advantage in both the hypofractionated and conventionally fractionated regimens compared with that seen with single fraction, open debulking field regimens, but the true therapeutic advantage exists only in the hypofractionated grid therapy. The clinical outcomes and our study indicated that a course of open-field radiotherapy is necessary to control tumor growth fully after a grid therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hualin Ph.D., Jian Z. Ph.D., Nina M.D., Xiang M.Sc., Jiankui Ph.D., Nilendu Ph.D., Simon M.D., John M.D., Joseph M.D., Douglas M.D., William M.D.,